Ready to start the day for a great AGA Leadership Summit. @amergastroassn.bsky.social

CDI testing, diagnosis, and treatment differ across specialties and settings. Survey findings support physician education and universal algorithms to improve consistency of care and patient outcomes. 🔗 https://ow.ly/3tqK50ZOiWe 🏷️ #FeaturedArticle

As we thank Gastro Hep Advances' inaugural Board, we are equally excited to welcome our new Editorial Board and Editor-in-Chief, Dr. Anisa Shaker. Here's to the next five years of discovery, innovation, and impact! 💚 🔗 https://ow.ly/IOlc50ZHqRc

📑 Current study underscores the role of liver stroma in liver pathology. Specifically, Msln/Muc16 signaling in portal fibroblasts contributes to age-related progression of cholestatic fibrosis and HCC 🔗 https://ow.ly/jxzi50ZwlKl 🏷️ #Fibrosis #LiverDisease

Don’t just watch the future of GI oncology unfold—help shape it. Submit your abstract to #GI27, the premier global event for specialized GI cancer research. Submit now at: https://bit.ly/4wBGxbS Co-sponsors: @amergastroassn.bsky.social, @astro-org.bsky.social & @socsurgonc.bsky.social

"The EoE Playbook: Evidence-Driven EoE Management" is now available on GastroCE! Earn #CME or #AAPA credit now: https://www.healio.com/cme/gastroce/eosinophilic-esophagitis/20260605/the-eoe-playbook-2/overview @amergastroassn.bsky.social

Our new pub in @aga-ghadvances.bsky.social! Survey of 302 US physicians found specialty-driven gaps in CDI management: 40% PCPs had no CDI guidelines; 84% prescribed metronidazole; <10% felt aware of microbial Rx. Time to standardize CDI care! @amergastroassn.bsky.social #AWSOM tinyurl.com/4sbby94v

"The EoE Playbook: Clues, Criteria, and Confirmation—Diagnosis, Management, and Access in Eosinophilic Esophagitis" is now available on GastroCE! Earn #CME or #AAPA credit now: https://www.healio.com/cme/gastroce/eosinophilic-esophagitis/20260605/the-eoe-playbook-1 @amergastroassn.bsky.social

"The EoE Playbook: Clues, Criteria, and Confirmation—Diagnosis, Management, and Access in Eosinophilic Esophagitis" is now available on GastroCE! Earn #CME or #AAPA credit now with this 3-part series: https://www.healio.com/cme/gastroce/eoeplaybook @amergastroassn.bsky.social

New Article in Gastroenterology & CGH ✨ Honored to share our research article on cultural barriers to clinical trials from SAIA-AGA’s groundbreaking Clinical Research Roundtable at #DDW2025: doi.org/10.1053/j.ga... Thanks to @amergastroassn.bsky.social for their partnership on this key initiative!

📢 Applications open for Gastroenterology Editor-in-Chief! Prestige, impact, and leadership await. Deadline Mar 6.

APPs: Your work in equity matters. Apply or nominate today for AGA-Pfizer Beacon of Hope Awards! Applications and nominations deadline: Feb. 9. gastro.org/beaconsofhope

AGA-Pfizer Beacon of Hope Awards for Gender and Health Equity

The prestigious AGA-Pfizer Beacon of Hope awards will honor the achievements of three women in the field of digestive disease.

gastro.org

From biologics and small molecules to AI-powered diagnostics, these were the clinical research articles that captured the most attention in 2025. 🔗 gastro.org/news/top-20-... @aga-gastro.bsky.social @aga-cgh.bsky.social @aga-tige.bsky.social @aga-ghadvances.bsky.social

Our new CPU, published in @aga-cgh.bsky.social, outlines 14 best practices, including when to pursue physiologic testing, biofeedback therapy, and careful patient selection before considering surgery. Read more: gastro.org/news/14-best...

What was new in GI care for 2025? Explore our latest clinical guidelines and practice updates — covering IBD, Crohn’s disease, gastroparesis, Barrett’s esophagus, and more — to support evidence-based patient care. 🔗 gastro.org/news/whats-n...

Managing ascites, volume overload, & hyponatremia in cirrhosis requires evidence-based care. Our new CPU in aga-gastro.bsky.social offers 13 practical tips to support decision-making and outlines future research needs. Read more: gastro.org/news/13-tips...

Dive deep into our latest #GastroDigest @aga-gastro.bsky.social 🆕🔥 🚨Turning #GutSensors into Therapeutic Switches: A #Sensorome Roadmap for Metabolic & Gut–Brain🧠Interaction Disorders‼️ @amergastroassn.bsky.social 🙌 Prof. Kara Margolis🙏😇 👉 www.gastrojournal.org/article/S001... #DGBI #GLP1 #Serotonin

🚨 New clinical practice update 🚨 Published in @aga-gastro.bsky.social, our latest CPU highlights endoscopic resection for early #colorectalcancer. Read more here: gastro.org/news/new-exp... @hopkinspress.bsky.social #GISky

🔎 In a study of over 1.8 million colonoscopies, physicians with lower polyp detection rates may also be missing cancers present at the time of colonoscopy, emphasizing the need for quality assurance. Read more at ow.ly/MAup50XFPkE

Apply or nominate for the AGA-Pfizer Beacon of Hope Awards for Gender and Health Equity! Deadline: Feb. 9. gastro.org/beaconsofhope #HealthEquity #WomenInGI

Key coding changes are coming Jan 1, 2026 for neurogastroenterologists and motility specialists: ☑️ EndoFLIP™ billable in ASCs ☑️ New CPT codes for ARM & barostat ☑️ New CPT code for IB-Stim® Read more here: gastro.org/news/motilit... #GISky

Motility coding changes coming in the new year

The American Gastroenterological Association (AGA) is the trusted voice of the GI community. AGA publishes top-tier journals, guidelines and patient education ...

gastro.org

IBD management is complex. Support your patients’ decision making by sharing the AGA IBD Drug Guide. This resource, created by IBD specialists, offers ways to filter treatment options to provide recommendations tailored to patient needs. Explore the resource: ibddrugguide.gastro.org.

A new review published in @aga-cgh.bsky.social underscores the need to limit corticosteroid use in IBD to less than 2️⃣ months. Read more here: gastro.org/news/limit-c... #GISky

Limit corticosteroid use to less than two months

The American Gastroenterological Association (AGA) is the trusted voice of the GI community. AGA publishes top-tier journals, guidelines and patient education ...

gastro.org

#MatchDay2026 is here! Today is the culmination of years of hard work, and we’re cheering on everyone learning their results! Tag @amergastroassn.bsky.social to share GI program matches – we can’t wait to give the #FutureOfGI a warm welcome from the #AGAGastroSquad! #FellowMatch #GIsky #GastroSky

🚨AGA New Guideline Alert🚨 @amergastroassn.bsky.social 🔗https://smplu.link/aga_CD_guidelines ▶️AGA Living Guideline: Pharmacologic Management of Moderate-to-Severe Crohn’s Disease I’ll break down its 16 recommendations down over the next 10 tweets 🧵 👇 #AGA #GI #CD #IBD #MedTwitter 1/10

Our review "The Role of Alcohol in Pancreatic Diseases: A Comprehensive Perspective" is now published in @aga-gastro.bsky.social @amergastroassn.bsky.social 🎉 Mechanisms of alcohol-induced injury, critical cofactors, and emerging therapies! Enjoy reading it! www.gastrojournal.org/article/S001...

The Role of Alcohol in Pancreatic Diseases: A Comprehensive Perspective

Alcohol abuse is a leading cause of global health care concerns and can cause health loss, disease, and death. In addition to the liver, the pancreas is a vital organ for the metabolism of alcohol, es...

gastrojournal.org

This #CrohnsAndColitisAwarenessWeek, explore the AGA IBD Drug Guide: a brand-new tool with information on potential IBD treatments and more. Use it to inform care options for your patients. Start here ➡️ ibddrugguide.gastro.org. #CCAwarenessWeek

📣 It’s #CrohnsColitisAwarenessWeek! Ready to take your IBD knowledge to the next level? Join us at the 2026 Crohn’s & Colitis Congress ✨ Register by Dec. 9 & save up to $166 ✨ Hotel deadline: Dec. 18 👉 crohnscolitiscongress.org?utm_medium=B... #IBD #CCCongress26 #CrohnsColitisAwarenessWeek

Author @frankiscottmd.bsky.social provides a great breakdown of our new living on managing moderate-to-severe Crohn’s disease. Clear, actionable insights for clinicians and patients alike. Looking forward to the full thread of recommendations. 👇

Frank I. Scott, MD MSCE@frankiscottmd.bsky.social · 11mo ago

🚨AGA New Guideline Alert🚨 @amergastroassn.bsky.social 🔗https://smplu.link/aga_CD_guidelines ▶️AGA Living Guideline: Pharmacologic Management of Moderate-to-Severe Crohn’s Disease I’ll break down its 16 recommendations down over the next 10 tweets 🧵 👇 #AGA #GI #CD #IBD #MedTwitter 1/10

Our new clinical practice guideline, published in AGA-Gastro.bsky.social, offers 16 evidence-based recommendations for treating moderate-to-severe #Crohnsdisease. Read more here: gastro.org/news/new-aga... @frankiscottmd.bsky.social #GISky